Schedule of assessment
Domain | Measure | Screening | Baseline | During treatment | 1-month follow-up | 3-month follow-up |
Eligibility | Demographic questionnaire | X | X | |||
Consent form | X | |||||
Medical history | X | |||||
MoCA | X | |||||
Medication | X | X | X | X | X | |
Primary outcome | Visual Analogue Scale | X | X | X | X | X |
Secondary outcomes | Brief Pain Inventory Short Form | X | X | |||
Blood sample—Inflammation markers | X | X | X | |||
Cognition | X | X | X | |||
Rivermead TBI symptoms | X | X | ||||
Short Musculoskeletal Function Assessment | X | X | ||||
Short Form Health Survey | X | X | ||||
Pittsburgh Sleep Quality Index | X | X | ||||
Beck’s Depression Inventory-II | X | X | X | |||
Beck’s Anxiety Inventory | X | X | X | |||
Other | Pain Catastrophising Scale | X | ||||
Treatment Expectation Questionnaire | X | |||||
PTSD Checklist for DSM-5 | X | X | ||||
Treatment assignation hypothesis | X | |||||
Opioid consumption | X | X | X | X | X | |
Adverse events | X | X |
DSM-5, The Diagnostic and Statistical Manual of Mental Illnesses; MoCA, Montreal Cognitive Assessment; PTSD, post-traumatic stress disorder; TBI, traumatic brain injury.